News & Events

Home | News | Zeno Pathology available in Founda Health platform

Zeno Pathology available in Founda Health platform

Zeno Pathology, WSK Medical’s CE certified Artificial Intelligence (AI) digital pathology solution, is available in the Founda Health platform.

With this integration, WSK Medical aims to allow Founda Health users to have direct access to a high-quality AI digital pathology solution for whole slide image analysis within their medical institution.  The Founda Health platform was developed to integrate innovative applications with healthcare providers. Their aim is to take away the integration barriers so that everyone can access digital innovations and start improving processes for doctors and care for patients. 

About Founda Health
Started in 2019 as a platform in healthcare. Since that time Founda Health has been building a solid foundation passionately. A foundation that connects healthcare providers, organizations, products and systems altogether. Their goal is to enable collaboration and innovation, to free-up time and space for care workers so they can focus all their energy on what they are best at. You can find more about Founda Health here.

About WSK Medical
WSK Medical bridges the gap between the medical sector and AI by developing easy-to-use, workflow integrated, clinically valuable AI systems for early cancer detection. We achieve this by translating complex, medical problems into solutions that assist doctors and clinicians in their daily work. Contact us for more information about our AI solutions!

Share –

Related articles

Zeno AI featured article on Open Access Government

The successful launch and implementation of Zeno AI, the first of its kind real-time AI solution for early laryngeal (throat) cancer detection for ENT-surgeons, was the subject of an article published by Open Access Government.


World Summit AI – Exhibiter – 12-13th of October in Amsterdam

What is World Summit AI?

The world’s leading and largest AI summit gathers the global AI ecosystem of Enterprise, Big Tech, Startups, Investors and Science, the brightest brains in AI as speakers every October in Amsterdam to tackle head-on the most burning AI issues and set the global AI agenda. You can find more information here.


WSK Medical part of the EMPAIA consortium

WSK Medical has signed a partnership agreement with the EMPAIA consortium. With this partnership, WSK Medical aims to add knowledge to the consortium about the development and deployment of AI solutions for early cancer detection.

Demo //

Book a demo

Want to learn more about our solutions?

Our website only uses essential cookies. These cookies are used to make the website function properly. By continuing your visit on our website, you understand this. All our privacy related matters can be found in our privacy policy.